论文部分内容阅读
我院自1992年7月开始应用乙肝康胶囊、乙肝康注射液治疗病毒性肝炎、肝硬化取得较好疗效,现报告如下:1 材料和方法1·1 临床资料 治疗组642例,男482例,女160例,年龄7～74岁,平均32.5岁,其中急性乙型肝炎282例,慢性乙型肝炎276例,肝炎后肝硬化84例,对照组306例,男229例、女77例,年龄8～70岁,平均30.5岁,其中急性乙型肝炎109例,慢性乙型肝炎114例,肝炎后肝硬化83例。上述病历均符合1990年
Our hospital since July 1992 application of Hegagang capsules, hepatitis B Kang injection treatment of viral hepatitis, cirrhosis and achieved better results are as follows: 1 Materials and methods 1.1 Clinical data 642 cases of treatment group, male 482 cases , Female 160 cases, aged 7 to 74 years old, average 32.5 years, of which 282 cases of acute hepatitis B, chronic hepatitis B 276 cases, 84 cases of posthepatitis cirrhosis, control group 306 cases, 229 males and 77 females, Aged 8 to 70 years, mean 30.5 years, of which 109 cases of acute hepatitis B, 114 cases of chronic hepatitis B, 83 cases of posthepatitis cirrhosis. The above medical records are in line with 1990